FDA approves new Alzheimer’s drug that appears to slow progression of disease

fda-approves-new-alzheimer’s-drug-that-appears-to-slow-progression-of-disease

FDA approved new Alzheimer’s drug shown to slow cognitive decline in patients in the early stages of the illness.

1 Shares:
You May Also Like